Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sobi
Marketing
FDA untitled letters target drug ads from Novo, argenx, Sobi
A batch of untitled letters posted on the FDA’s database in recent days takes aim at what the agency has termed “false or misleading” drug ads.
Andrea Park
Feb 10, 2026 11:42am
Sobi tops Roche in rare disease patients' reputation rankings
Sep 23, 2025 12:33pm
Sobi places $300M bet on Empaveli in partnership with Apellis
Jul 1, 2025 11:28am
Novartis, Apellis roll out rival datasets in rare kidney disease
Oct 28, 2024 10:03am
Watch out, Novartis. Apellis scores major win in kidney diseases
Aug 8, 2024 2:28pm
Sobi boosts hematology sales with growth across key brands
Jul 16, 2024 1:27pm